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Inflammatory monocytes are key early responders
to infection that contribute to pathogen-host interac-
tions in diverse ways. Here, we report that the murine
cytomegalovirus-encoded CC chemokine, MCK2,
enhanced CCR2-dependent recruitment of these
cells to modulate antiviral immunity, impairing
virus-specific CD8+ T cell expansion and differentia-
tion into effector cytotoxic T lymphocytes, thus
reducing the capacity to eliminate viral antigen-
bearing cells and slowing viral clearance. Adoptive
transfer of inflammatory monocytes into Ccr2/
Ccl2/ mice impaired virus antigen-specific clear-
ance. Cytomegalovirus therefore enhances a natural
CCR2-dependent immune regulatory network to
modulate adaptive immunity via nitric oxide pro-
duction, reminiscent of the monocytic subtype of
myeloid-derived suppressor cells primarily impli-
cated in cancer immunomodulation.
INTRODUCTION
Monocytes are crucial in host defense against a broad range of
microbial and viral pathogens, differentiating into macrophages
and dendritic cells (DCs) that shape innate as well as adaptive
immunity. In mice, CD11b+CD115+F4/80+ blood monocytes,
initially characterized by CX3CR1, Gr-1, and CCR2 expression,
are divided into bone marrow (BM)-resident CX3CR1
intCCR2+
Ly6Chi inflammatory monocytes (IMs) and long-lived CX3CR1
hi
CCR2Ly6Clo patrolling monocytes (Geissmann et al., 2003;
Serbina and Pamer, 2006; Sunderko¨tter et al., 2004). CCR2
signaling controls IM egress from BM into the bloodstream and
tissues (Serbina and Pamer, 2006), whereas constitutive
CX3CR1-mediated signals provided by endothelial cells sustain
patrolling monocytes (Geissmann et al., 2003; Landsman et al.,
2009; Sunderko¨tter et al., 2004). Paralogous human subsets
have been proposed on the basis of the differential expression
of the markers CD14 and CD16 (Robbins and Swirski, 2010;
Serbina and Pamer, 2006), although functional parallels with
mice remain to be fully elucidated. The dramatic activation of
murine IMs from BM is a hallmark of the host response to local-
ized or systemic insult, suggesting that these cells help shape
adaptive immunity.
Macrophages, tumor necrosis factor (TNF) and inducible nitric
oxide (NO)-producing DCs (TipDCs; Serbina and Pamer, 2006),122 Immunity 37, 122–133, July 27, 2012 ª2012 Elsevier Inc.and mononuclear myeloid-derived suppressor cells (MDSCs;
Movahedi et al., 2008) all develop from mobilized IMs, exhibiting
diverse roles including direct control of microbes, immuno-
pathology, immunostimulation, and immunosuppression. IM-
derived macrophages and TipDCs protect by directly killing
microbes (Shi and Pamer, 2011). The role of IMs in viral infections
seems context specific—protecting from West Nile virus (Lim
et al., 2011), mediating disease pathology by influenza virus
(Lin et al., 2008), and suppressing T cells responses to Theiler’s
murine encephalomyelitis virus (Bowen andOlson, 2009). IM-like
MDSCs have long been associated with suppression of CD8+
T cell function in models of tumor immunity (Movahedi et al.,
2008). In cytomegalovirus (CMV) infection, IM mobilization is
a hallmark of the inflammation that stimulates a robust antiviral
natural killer (NK) cell response to limit disease consequences
(Crane et al., 2009; Hokeness et al., 2005); however, any contri-
bution to shaping adaptive immunity remains unexplored.
CMVs are highly species-specific betaherpesviruses encod-
ing modulators that target cell-intrinsic, innate, and adaptive
immunity (Crane et al., 2009; Mocarski et al., 2007). The biolog-
ical similarities between human and murine CMV (HCMV and
MCMV, respectively) aswell as their common targeted pathways
have facilitated understanding of key host and virus-encoded
factors modulating the host-pathogen balance (Babic et al.,
2011; Hengel et al., 1998; Hengel et al., 1999; Mocarski et al.,
2007). Viral modulators dampen host clearance mechanisms
and sometimes exploit the response. Monocytic cells play
a central role ferrying virus from initial sites of infection via the
blood stream (Stoddart et al., 1994). The proinflammatory factor
encoded by m131/129, MCMV CC chemokine 2 (MCK2), mobi-
lizes monocytes as vehicles for dissemination to salivary glands
(SGs) (Fleming et al., 1999; Saederup et al., 2001; Saederup
et al., 1999). MCK2 enhances leukocyte recruitment and viral
dissemination in C57BL/6 mice, in which innate NK cell control
predominates (Crane et al., 2009; Hokeness et al., 2005), as
well as in BALB/cmice (Noda et al., 2006), where adaptive immu-
nity is crucial for host control of infection (Biron et al., 1999;
Koszinowski et al., 1990). MCK2 also impedes NK and T cell-
mediated clearance of infection (Fleming et al., 1999), without
altering peak viral replication levels (Saederup et al., 2001).
Thus, it is important to understand the extent ofMCK2-enhanced
IM recruitment and the role of these cells in shaping immunity.
In the C57BL/6 model of CMV infection where the immunosti-
mulatory virus-encoded gene product, m157, activates NK cells
via Ly49H (Arase et al., 2002), IFN-ab drive CCR2-dependent IM
mobilization that promotes NK cell-mediated viral clearance
(Crane et al., 2009; Hokeness et al., 2005). The resulting robust
NK cell response reduces viral replication levels and dampens
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Ly49H-m157-NK axis is absent in BALB/c mice, as well as
most wild mice, in which viral clearance is predominantly CD8+
T cell mediated. A Gr-1intCD11b+, BM-resident, IM-like mono-
cytic population (Noda et al., 2006) is mobilized during infection
of BALB/cmice. Given the extent to which immune control, path-
ogenesis, and dissemination have been tied to the behavior of
monocytic lineage cells (Hokeness et al., 2005; Klemola and
Ka¨a¨ria¨inen, 1965; Noda et al., 2006; Presti et al., 2001; Saederup
et al., 1999; Sissons et al., 1991; Stoddart et al., 1994), we set out
to determine how IMs shape host defense in BALB/c mice. We
report that CCR2-dependent, BM-derived IMs inhibited CD8+
T cell activation and cytotoxic activity via an iNOS-mediated
NO production pathway, contributing to slower viral clearance.
In this way, viral MCK2 synergized with host CCR2 signaling
to enhance the natural IM mobilization and sustain viral
persistence.
RESULTS
Recruitment of CCR2-Dependent IMs during MCMV
Infection
MCMV induces a dramatic viral chemokine-dependent inflam-
matory response at the inoculation site (Noda et al., 2006;
Saederup et al., 2001). We set out to define the myeloid cells
recruited to the footpad (FP) site of infection previously charac-
terized as Gr-1intCD11b+CD45+ leukocytes. The developing
understanding of IMs prompted the use of Ly6C as a marker,
which facilitated the identification of a Ly6ChiCD11b+ population
recruited to infected FPs (Figure 1A). Surprisingly, we found that
these Ly6Chi IMs had low levels of Gr-1 compared to Ly6Cint
polymorphonuclear leukocytes (PMNs), which showed the ex-
pected Gr1hiLy6G+Ly6CintCD11b+ phenotype (Figure 1B and
Figure S1 available online). We therefore relied on Ly6C and
CD11b as defining markers for IMs (Crane et al., 2009; Serbina
and Pamer, 2006; Sunderko¨tter et al., 2004), an approach found
useful by others (Dolcetti et al., 2010; Movahedi et al., 2008;
Nagendra and Schlueter, 2004). IM recruitment continued as
infection proceeded but declined in mock-inoculated mice
(Figures S1D and S1E). When purified, IMs (gate R1) displayed
the characteristic morphology of large (15 mm), granular,
mononuclear cells with high cytoplasm to nucleus ratios (Geiss-
mann et al., 2003) (Figure S1F), consistent with previous studies
of this population in MCMV-infected C57BL/6 mice (Crane et al.,
2009). IMs and PMNs (R2) together represented the majority
(63%) of CD45+ FP infiltrates at 3 days postinfection (dpi). R2
cells exhibited the features of PMNs (Figure S1F). The remaining
populations represented NK cells, DCs, B cells, T cells, and
patrolling monocytes (data not shown). The recruited IMs
expressed CD115 (macrophage colony-stimulating factor re-
ceptor [CSF-1R or c-Fms]) and F4/80 and had low expression
of Ly6Gwith the expected high expression of the adhesionmole-
cules CD31 and CD62L as well as the stem cell antigen (Sca-1)
(Figure 1C), but lacked lineage-specific markers for DCs
(CD11c), NK cells (CD49b), B cells (CD19), or T cells (CD3ε,
CD4 and CD8a; data not shown). Thus, the phenotype Gr1lo
Ly6ChiCD11b+ CD115+F4/80+Ly6GloCD11cCD49b identified
an IM population prominently recruited during MCMV infection
of BALB/c mice.As expected (Serbina and Pamer, 2006), the emigration of IMs
from BM was tightly regulated by CCR2-mediated signaling.
Whereas wild-type (WT) BALB/c mice exhibited a sustained IM
response at the inoculation site (Figures 1D, S1D, and S1E),
increasing 5-fold between 1 and 3 dpi and continuing to accumu-
late through 5 dpi (Figure 1E), IMs were poorly recruited in
Ccr2/–Ccl2/– BALB/c mice (Figures 1D and 1E). CCR2 defi-
ciency severely compromised IM recruitment but did not alter
trafficking of the other leukocyte populations, including PMNs,
Ly6CCD11b, Ly6CCD11b+, and Ly6C+CD11b cells or
Ly6C/loCD11b+ patrolling monocytes (Figure 1D). Accordingly,
IM recruitment was substantially reduced in the absence of
CCR2 and CCL2 (Figure 1D, bottom panels), even at later times
(5 dpi), suggesting that additional signals contribute to recruit-
ment. Reduced IM recruitment correlated with reduced FP
swelling in Ccr2/–Ccl2/– mice at 3 dpi (Figure 1F). Overall,
IMs were the predominant mononuclear population naturally
recruited to the initial infection sites.
The distribution of IMs in blood and lymphoid tissues was eval-
uated. In contrast to their patterns in WT mice, IMs accumulated
in the BM of infected Ccr2/–Ccl2/– mice and did not appear in
blood, spleen, or other sites (Figures 1G–1K, S1G, and S1H).
Together, these results indicated that BM was the source and
site of turnover of IMs and that the innate response to infection
was marked by CCR2-dependent recruitment of these cells out
of the BM via the bloodstream to sites of infection. Importantly,
the late myeloid progenitors identified previously without the
benefit of a Ly6C-specific antibody (Noda et al., 2006) are clearly
Ly6Chi IMs.
Viral Chemokine Controls Recruitment of IMs
to Infected Footpads
MCK2 is a proinflammatory CC chemokine that promotes
monocyte-associated viremia and leukocyte recruitment to
initial sites of infection (Fleming et al., 1999; Noda et al., 2006;
Saederup et al., 2001). To evaluate the impact of the viral chemo-
kine on the recruitment of IMs, we compared responses at
the FP inoculation site in WT mice infected with Mck2-express-
ing, rescued virus (RQ461) or Mck2 null mutant (RM461)
(Saederup et al., 2001; Stoddart et al., 1994). Infection with the
chemokine-deficient virus resulted in a 50% decrease in IM
frequency at 3 dpi (Figure 2A, top panels), as well as fewer
IMs in peripheral blood and spleen (Figures S2A–S2C). At the
same time, greater numbers of IMs were detected in the draining
popliteal lymph node (pLN). Mutant virus also recruited fewer
PMNs but similar numbers of other leukocyte populations
(data not shown). Next, we inoculated Ccr2/–Ccl2/– mice
with Mck2 mutant or rescued viruses in order to evaluate
whether the viral and host chemokines collaborate in the
recruitment of IMs. CCR2-CCL2 deficiency reduced IM numbers
by 100% (3 dpi) and 87% (5 dpi) (Figure 2B). The combination of
host CCR2-CCL2 and viral MCK2 deficiency abolished IM
recruitment at all times (Figures 2A and 2B). Notably, poor IM
recruitment was not due to poor replication, given that both
viruses showed similar peak titers in WT and mutant mice
(Figure S2B; Fleming et al., 1999; Noda et al., 2006; Saederup
et al., 2001). Although fewer IMs were recruited in the absence
of either host CCR2 signaling or the viral chemokine (Fig-
ure 2B), the time course of recruitment during infection withImmunity 37, 122–133, July 27, 2012 ª2012 Elsevier Inc. 123
Figure 1. MCMV Recruits CCR2-Dependent
IMs during Infection
(A–C) Flow cytometric analysis of myeloid cells in
inoculated FPs at 3 dpi.
(A) Resolution of mononuclear Gr-1loLy6Chi
CD11b+ (R1) cells from Gr-1hiLy6C+CD11bhi (R2)
PMN.
(B) Efficiency of the Gr1 marker in resolving
CD11b+ subsets.
(C) Expression of monocyte subset defining
markers on R1 gated cells. Solid line histograms,
IMs; dashed lines, positive control; closed lines,
negative control.
(D–F) Recruitment of Gr-1loLy6ChiCD11b+ IMs into
inoculated FPs of WT and Ccr2/Ccl2/ (DKO)
mice.
(D) Scatterplots comparing cellular infiltrates.
(E) Total IMs.
(F) FP swelling.
(G–K) Distribution of IMs in tissues at 5 dpi.
(G) Scatterplots of leukocytes.
(H–K) IM frequencies in BM (H), blood (I), spleen (J),
pLN (K). Mice were inoculated via the FP route with
106 PFU MCMV. Scatterplots represent groups of
three mice. Elliptical gates outline IMs. Histograms
show one representative mouse per group (gray,
negative control; dash line, positive control; solid
line, IMs). Data points are means ± SE. *p < 0.05;
**p < 0.01; ***p < 0.001. Panels show one repre-
sentative of at least two independent experiments.
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than the chemokine-deficient virus in WT mice. Although,
expression of the viral CC chemokine precipitated IM recruit-
ment to the inoculated site, MCK2 does not stimulate cells via
CCR2 (data not shown). Thus, MCK2 cooperates with host124 Immunity 37, 122–133, July 27, 2012 ª2012 Elsevier Inc.CCR2-mediated signaling to assure IMs
are mobilized from BM to sites of
infection.
IMs InfluenceMCMVClearance, but
Are Not Vehicles of Dissemination
We infected WT or Ccr2/–Ccl2/–
mice and followed viral titers in organs
known to be involved in viral pathogen-
esis to assess whether IM recruitment
altered viral clearance. Virus was de-
tected in spleen, liver, and lungs indepen-
dently of CCR2 signaling (Figures
3A–3C), as previously reported (Noda
et al., 2006), peaking at the same time
(3 dpi) in the spleen and liver of WT and
mutant mice (Figures 3A and 3B). Here,
virus titers peaked earlier in the lungs
of mutant (5 dpi) than in WT mice (7 dpi)
(Figure 3C). Overall, virus was cleared
earlier from lungs and more rapidly from
spleens of Ccr2/–Ccl2/– mice (7 dpi),
suggesting a compromise in immunity
when IMs were recruited (Figures 3A
and 3B). Concurrent with rapid viralclearance in Ccr2/–Ccl2/– mice, acute host-associated
disease pathogenesis was more pronounced, whether as-
sessed by weight loss (Figure 3D) or coat appearance (data
not shown). Additionally, Mck2-deficient virus was cleared
more rapidly from spleen and lungs of WT mice (Figure S2B),
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Figure 2. Virus-Encoded MCK2 Cooperates with Host CCR2
to Recruit IMs
(A) Scatterplots of FP cellular components at 3 dpi. Elliptical gate, IMs.
(B) Total IMs. Mice were inoculated withMck2-expressing (rescued) orMck2-
deficient (mutant) MCMV. At specified time points, leukocytes were isolated
and evaluated by flow cytometry. Plots show one animal representative of
groups of three mice. Symbols on graph represent mean ± SE. Panels show
one of least two independent experiments.
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Inflammatory Monocytes Impair MCMV CTL Immunityrevealing the impact of fewer IMs in the absence of viral chemo-
kine. These results point to a role of IM-derived cells in modu-
lating immune clearance.
MCMV disseminates within a monocytic cell via the blood
stream to the SG (Stoddart et al., 1994), an important site of pro-
longed replication and source of transmitted virus. The efficiency
of viral dissemination to the SG is a recognized predictor of the
success of this pathogen in the host (Lagenaur et al., 1994;
Manning et al., 1992), as recently highlighted with bacmid-
derived virus (Jordan et al., 2011). Although viral persistence in
lungs and spleen was reduced in the absence of IM recruitment
in Ccr2/–Ccl2/– mice, this did not compromise dissemination
to SGs (Figure 3E), as previously established in Ccr2/–,
Ccl2/–, and Ccr2/–Ccl2/– mice (Noda et al., 2006). The poor
dissemination of Mck2-deficient virus in WT (Figure S2C) and
Ccr2/–Ccl2/– mice (Noda et al., 2006) suggests that a non-IMblood cell population acts as the vehicle for dissemination.
Further, the ability of MCMV to establish latency was not altered
by differences in IM recruitment in WT or mutant mice, given that
reactivation was observed after 7 days in explanted spleen, lung,
or SGs, with 100% of the explants becoming virus positive by
35 days of culture (Figure 3F). Although viral clearance from lungs
and spleen is influenced by IM recruitment, viral persistence
levels and latency set points are not compromised. Thus, IM
lineage cells do not play a direct role in dissemination or latency.
IM Mobilization Impairs MCMV-Specific CD8+ T Cell
Response
To investigate IM-associated reduced clearance of MCMV, we
evaluated the antiviral CD8+ T cell response. In BALB/c mice,
many cytotoxic T lymphocytes (CTLs) recognize a major MHC
class I Ld epitope within the viral IE1 (pp89) protein to clear
virus-infected cells (Koszinowski et al., 1990). When the splenic
immune response in infected Ccr2/–Ccl2/– or WT mice was
evaluated at 7 dpi, expansion of leukocyte numbers was signifi-
cantly greater in mutant mice (Figure 4A). Total numbers of
CD8+ T cells did not increase during infection in WT mice, but
increased markedly in infected mutant mice (Figure 4B). Addi-
tionally, Ccr2/–Ccl2/– mice had twice as many MCMV-specific
IE1 tetramer-positive CD8+ T cells asWTmice even though over-
all frequencies of Ag-specific T cells were similar at this time (Fig-
ure 4C). Infection of WTmice with eitherMck2 rescued or mutant
virus did not lead to differences in total CD8+ T cells, but mutant
virus induced significantly higher frequencies of IE1-specific cells
(Figures S2D and S2E). Thus, IM recruitment influences the Ag-
driven proliferative response of MCMV-specific CD8+ T cells.
To evaluate the differentiation state of MCMV-specific CD8+
T cells, we performed multiparameter flow cytometric analysis
on IE1-specific CD8+ T cells. BothWT andmutantmice exhibited
Ag-specific T cells with a KLRG1hiCD44+CD127CD62L short-
lived effector CTL phenotype; however, there was a disparity in
KLRG1 expression (Figure 4D). Whereas the Ccr2/–Ccl2/–
Ag-specific CD8+ T cells were uniformly KLRG1hi, a phenotype
that is expected at 7 days after an acute viral infection (Joshi
et al., 2007; Sarkar et al., 2008), cells from WT mice contained
equal proportions of KLRG1 and KLRG1hi subsets (Figure 4D,
left panel) consistent with a delayed activation state (Sarkar
et al., 2008). Similar to Ccr2/–Ccl2/– mice, IE1-specific CTLs
induced during Mck2 mutant virus infection of WT mice were
uniformly KLRG1hi (Figure S2F). The presence of IE1 tetramer-
positive CD8+ T cells lacking both KLRG1 and CD127 (IL7Ra)
at 7 dpi in Mck2 rescue virus-infected WT mice was consistent
with fewer cell divisions after activation (Joshi et al., 2007). The
aggregate data provided the initial key evidence that IM recruit-
ment alters proliferation aswell as quality of antiviral CD8+ T cells.
For further characterization of the response, virus-specific
CD8+ T cells from WT and mutant mice were stimulated
ex vivo with the immunodominant nonapeptide, IE1YPHFMPTNL
(Reddehase et al., 1989), and assessed by intracellular cytokine
staining. Numbers of IFN-g-producing CD8+ T cells from WT
mice peaked at 5 dpi and decreased by 10 dpi, whereas cells
from Ccr2/–Ccl2/– mice increased dramatically by 7 dpi and
continued to accumulate through 10 dpi (Figures 4E, S3A, and
S3B). WT mice generated high numbers of TNF+ IE1-specific
CD8+ T cells (Figures 4E, 4F, S3A, and S3C), including bothImmunity 37, 122–133, July 27, 2012 ª2012 Elsevier Inc. 125
Figure 3. IM Recruitment Impacts MCMV
Clearance but Not Establishment of Infec-
tion and Latency
(A–C) Viral titers at 1, 3, 5, 7, and 14 dpi in tissues
of WT (triangle, black lines) and DKO (circles,
gray lines) mice. Symbols represent individual mice
and lines connect mean values at each time
point. *p < 0.05; ***p < 0.001; n.s., not significant
(p > 0.05).
(D) Weight change. Symbols represent mean ± SE
in groups of three mice.
(E) Viral titers in SGs at 14 dpi showing log10 mean
titers ± SE.
(F) Latency and reactivation of MCMV in explanted
tissues. Tissues were collected at 6 months post-
infection, sectioned into three portions, and
cultured for 35 days. Supernatant was sampled at
weekly intervals and viral titers were obtained by
plaque assay. Bars represent the percentage ± SE
of animals whose tissue yielded virus. Groups of
4-5 mice were evaluated and experiment was
replicated twice. Dashed lines represent the limit of
detection of the assay.
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left panel) peaking at 5 dpi (Figure 4F). In contrast, CD8+ T cells
fromCcr2/–Ccl2/– mice yielded a pattern associatedwith func-
tional antiviral T cells (Seder et al., 2008) with a predominance of
IFN-g single-positive along with IFNg+TNF+ bifunctional cells
(Figure 4G, bottom-left panel). Thus, TNF single-positive T cells
appeared to retain a naive phenotype (Brehm et al., 2005)
despite coming from virus-infected animals. Single-positive
T cells from WT mice contained lower amounts of cytoplasmic
TNF than bifunctional T cells (Figure 4G, top and bottom, left
panels). Thus, IM recruitment delays T cell differentiation toward
an effector phenotype.
In addition to differences in intracellular cytokines, there was
a significant defect in the cytolytic potential of T cells from WT
mice (Figure 4I). Only few (15%–30%) TNF+ CD8+ T cells ex-
pressed the degranulation marker, CD107a, compared to the
70%–90% of the bifunctional cells from Ccr2/–Ccl2/– mice
(Figures 4I and 4G, middle panels). A substantial proportion126 Immunity 37, 122–133, July 27, 2012 ª2012 Elsevier Inc.(60%–90%) of bifunctional CD8+ T cells
in either WT or mutant mice expressed
this cytolytic marker; although expression
in Ccr2/–Ccl2/– mice was generally
higher (Figure 4I).Consistentwith the trend
of reduced total CD8+ T cells, there were
fewer perforin-producing cells in WT than
mutant mice, even though frequencies
were similar (Figure 4J). Finally, CD69
and PD-1 were not detected on cytokine-
producing CD8+ T cells fromWTormutant
mice (Figure 4G, right panels, and data not
shown). Thus, IM recruitment compro-
mises the generation of fully functional,
virus-specific T effector cells.
Differences between WT and mutant
mice were even more striking when
virus-specific CD8+ T cells from pLNsthat drain inoculated FPs were examined (Figures 4H and S3).
Most (70%) CD8+ T cells in WT mice were TNF single-positive
cells whereas the majority (74%) were bifunctional in
Ccr2/–Ccl2/– mice (Figure 4H). Combined, the spleen and
pLN data suggest that viral persistence observed in the lungs
and spleen of WT BALB/c mice is due to a global suppression
of virus-specific CTL proliferation and differentiation.
IMs Impair CD8+ T Cell Effector Function
The conspicuous differences observed in WT and Ccr2/–
Ccl2/– mice prompted direct evaluation of effector activity of
virus-specific CD8+ T cells. To assess function, in vivo CTL
assays were conducted to compare clearance of adoptively
transferred CFSE-labeled, IE1 peptide-loaded target cells in
infected WT and mutant mice. When performed at 7 dpi,
CTL-mediated lysis was significantly more complete in
Ccr2/–Ccl2/– (87% specific killing) than in WT (60% specific
killing) mice within 3 hr after transfer (Figures 5A and 5B). Even
Figure 4. Recruitment of IMs Modulates the Differentiation of Virus-Specific CTLs
(A and B) Total numbers of lymphocytes (A) and CD8+ T cells (gated as CD3+CD4) (B) in spleen shown as mean values ± SE. Open bars; mock infected, filled
bars; MCMV-infected.
(C and D) IE1-tetramer (tet)+ CD8+ T cells.
(C) Total numbers (left panel) and frequency (right panel) as mean values ± SE.
(D) Expression of differentiation markers. Splenocytes were collected from naive or infected mice at 7 dpi. IE1-tet+ CD8+ T cells were analyzed for the expression
of effector andmemory differentiation markers. Five mice were evaluated per group. Data are representative of seven experiments. Open histograms, naive; gray
filled, solid line, WT mice; dashed line; DKO mice.
(E–J) Quality of the splenic CD8+ T cell response after peptide stimulation. Shown are expansion and contraction phases of (E) IFN-g- and (F) TNF-producing cells,
showing mean ± SE. The differentiation state of cells in the (G) spleen and (H) pLN is shown. Shown in (I) is the frequency of CD107a+ TNF+ and IFN-g+TNF+ CD8+
T cells as mean values ± SE. (J) shows the levels of perforin (Prf+)-expressing cells. Cells were evaluated at 7 dpi by ICCS after IE1 peptide stimulation in vitro.
*p < 0.05; **p < 0.01; ***p < 0.001.
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Figure 5. IMs Mobilized in WT Mice during MCMV Infection Inhibit
CTL Killing
(A and B) In vivo CTL assay.
(A) Frequency of CFSEhi cells after adoptive transfer intomock or infectedmice
at 3 hr after transfer. Histograms of CFSE-labeled cells prior to transfer (top) or
from one representative mock (middle) or MCMV-infected (bottom) recipient
mouse from groups of five mice are shown.
(B) Percent-specific killing shown as mean ± SE. *p < 0.05; **p < 0.01. Sple-
nocytes from naive DKO or WT mice were CFSE-labeled (CFSEhi), pulsed with
IE1 peptide, combined with CFSElo peptide-free cells then adoptively trans-
ferred into syngeneic mock or infected mice at 7 dpi. Spleens from recipient
mice were evaluated at 3 or 15 hr after transfer. Experiments were replicated
twice and yielded similar results.
Figure 6. MCMV Induced IMs Impair CD8+ T Cell Response to
Antigen
(A–C) In vitro suppression of Ag-specific CD8+ T cell proliferation by IMs.
(A) Proliferation in response to IE1 peptide stimulation in the presence of
increasing numbers of IMs.
(B) Percent suppression of proliferation by IMs.
(C) Frequency of dead (7-AAD+) CD8+ T cells per well. Splenocytes were
collected from infectedmice at 7 dpi. CFSE-labeled DKO splenocytes (53 105
cells per well) were stimulated with IE1 peptide along with increasing
frequencies of IMs purified from WT spleens. At day 3 of incubation, CD8+
T cells were harvested and analyzed for CFSE dilution and 7-AAD detection.
Assay was done in triplicate and repeated three times with similar results.
(D and E) In vivo suppression of CD8+ T cells by IMs.
(D) Total CD8+ T cells recovered at 7 dpi from spleens of DKO mice adoptively
transferred with IMs from WT mice.
(E) Viral burden in spleens. IMs were purified from spleens of infectedWTmice
at 3 dpi and adoptively transferred via tail vein injections into DKO mice within
1 hr of FP inoculations with MCMV. At 7 dpi, tissues were harvested and
assessed by plaque assay showing log10 mean ± SE. *p < 0.05; **p < 0.01;
***p < 0.001. Plots are of one animal representative of each experimental
group; n = 5 mice. Similar results were obtained from five independent
experiments.
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clearing Ag-loaded cells (Figure 5B). Thus, the recruitment of
IMs compromised cytolytic functions of antiviral CTLs.
To directly assess the impact of IMmobilization on CTL-medi-
ated killing in vitro, we incubated increasing doses ofCcr2+/+ IMs
from 7 dpi spleens with IE1-stimulated, CFSE-labeled spleno-
cytes from 7 dpi Ccr2/–Ccl2/– mice. At 3 dpi, Ag-stimulated
proliferation, as measured by CFSE dilution, revealed a direct
correlation between IM numbers and the CD8+ T cell proliferative
response (Figure 6A). As the proportion of IMs in the cultures was
increased from 1.5% to 24%, proliferation was suppressed from128 Immunity 37, 122–133, July 27, 2012 ª2012 Elsevier Inc.
Figure 7. iNOS Mediates MCMV-Induced IM
Suppression of Virus-Specific CD8+ T Cell
Proliferation
(A and B) Suppression of CD8+ T cell proliferation
by IMs in the presence of metabolic inhibitors.
(A) Percent suppression with inhibitors L-NMMA
(NOS), nor-NOHA (arginase-1), and SOD (ROS),
showing mean ± SE for n = 3 mice. CFSE-labeled
DKO splenocytes were stimulated in the presence
of purified Ccr2+/+ IMs (24% of DKO splenocyte
numbers) as described above. CD8+ T cells were
harvested on day 3 of incubation and analyzed by
flow cytometry.
(B) NO2
 detection using the Greiss reagent assay
as mean values ± SE. Assays were done on groups
of three mice and repeated three times with similar
results.
(C and D) Effect of NOS-inhibition on MCMV
infection in vivo. Virus titers (C) and total (D; left)
and IE1-tet+ (D; right) CD8+ T cell numbers are
shown. Mice were given sterile drinking H2O with
or without L-NMMA, L-NAME, or L-NIL 3 days prior
to inoculation and throughout the course of infec-
tion then evaluated at 7 dpi. Data are as mean
values ± SE of treatment groups; n = 5.
(E) Functional phenotype of MCMV-induced IMs.
IMs in blood and tissues from 3 dpi WT mice were
analyzed for expression of MDSC markers and
cytokines. Data shown for one mouse represen-
tative of group size; n = 3 (solid line histogram, IMs;
dashed lines, PMNs; closed histograms, naive
lymphocytes). Similar results were obtained in two
independent experiments.
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increase in frequency of T cell death (7-AAD+; Figure 6C). To
evaluate the physiological relevance of the suppression
observed in vitro, we adoptively transferred purified Ccr2+/+
IMs into Ccr2/–Ccl2/– recipients within 1 hr of FP inoculation
and assessed CD8+ T cell activation (expansion) and functional
differentiation (ability to clear virus from spleens) at 7 dpi. Trans-
fer of only 6.7 3 104 IMs into infected Ccr2/–Ccl2/– mice was
sufficient to limit T cell expansion (Figure 6D) and increase viralImmunity 37, 122–titers (Figure 6E) to those of WT mice.
Transfer of either 2 3 105 or 6 3 105 IMs
prevented T cell expansion and delayed
viral clearance, recapitulating the pheno-
type in WT mice while also supporting
a modulatory role for IMs on T cells. Over-
all, IMs were sufficient for restricting Ag-
specific CD8+ T cell expansion and delay
virus clearance from tissues.
Nitric Oxide Production Facilitates
IM Impairment of Antiviral CD8+
T Cells
The IM-dependent impairment of antiviral
T cell function appeared reminiscent of
the mononuclear MDSCs implicated in
regulation of tumor immunity (Movahedi
et al., 2008). To test whether these effectswere similarly dependent on IFN-g-regulated gene products,
iNOS, ROS, or arginase-1 (Movahedi et al., 2008), we assessed
the impact of inhibitory drugs L-NMMA (NOS/iNOS), superoxide
dismutase (ROS), and nor-NOHA (arginase-1) on the ability of
IMs to suppress the CD8+ T cell proliferative response. The
suppressive activity of IMs correlated with iNOS-dependent
production of NO2
 as L-NMMA was the only drug that modu-
lated the response (Figures 7A and 7B). Inhibition of ROS or argi-
nase-1 activity had no impact on IM-mediated suppression. Any133, July 27, 2012 ª2012 Elsevier Inc. 129
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whereas nor-NOHA and superoxide dismutase, even together,
did not. To evaluate the impact of NOS activity in vivo, we treated
WTmice with pan NOS inhibitors (L-NMMA or L-NAME) or L-NIL
(iNOS-specific) 3 days prior to and during the course of MCMV
infection andweighed them tomonitor for any additional adverse
effects. Mice were analyzed at 7 dpi for tissue virus loads along
with splenic CD8+ T cell responses (Figures 7C and 7D). In
contrast to L-NMMA-treated (Tay and Welsh, 1997) or iNOS-
deficient MCMV-infected C57BL6 mice (Zhang et al., 2007) in
which virus titers increased in the absence of NOS activity, treat-
ment of BALB/c with this NOS inhibitor reduced virus titers in the
lungs, spleen, and pLN but not SGwhen compared to untreated,
infected mice (Figure 7C). L-NAME and L-NIL treatment yielded
similar results with the exception that lower virus titers were
observed in SGs. None of the drugs caused additional weight
loss or reduced virus titers at the inoculation site (data not
shown). CD8+ T cell proliferation appeared to be delayed in
spleens of mice treated with the NOS inhibitory drugs yet viral
replication was effectively controlled (Figure 7D). The reduced
expansion contrasted in vitro observations in which an increase
in T cell proliferation occurred when NOS was inhibited. This
discrepancy may be attributed to potential off-target drug
effects, although the absence of the restrictive effect of NO on
T cell function probably results in a more efficacious control of
viral burden in these mice, negating the requirement for large
CTL numbers. These data illuminate the significance of CD8+
T cell quality over quantity, suggesting that NO production
impacts the effectivenesss of the antiviral response. Overall,
the data are consistent with a key role for the iNOS-NO pathway
in IM-dependent impairment of the antiviral T cell response.
To determine the relationship of MCMV-induced IMs to
MDSCs, we evaluated Ly6Chi monocytes in the BM, blood,
spleen, pLN, and inoculated FPs for markers that have been
used to define the MDSC population. Consistent with previous
studies (Movahedi et al., 2008), IMs upregulated the expression
of iNOS and IL-4Ra, a hallmark receptor on mononuclear
MDSCs (Gallina et al., 2006), while trafficking from BM to in-
fected tissues (Figure 7E). Additionally, TNF and IL-10 produc-
tion developed as IMs reached tissues, reflecting an immature,
dual M1-M2 phenotype of mononuclear MDSCs (Umemura
et al., 2008; Figure 7E).
To address whether IM-induced expansion of regulatory CD4+
T (Treg) cells (Huang et al., 2006) contributed to the suppression
of anti-viral CD8+ T cells, we evaluatedCD25+CD4+ lymphocytes
in WT andCcr2/–Ccl2/– animals. Mutant mice controlled infec-
tion better than WT mice despite having markedly greater
numbers of splenic CD25+CD4+ T cells (data not shown),
indicating little or no contribution of regulatory CD4+ T cells to
IM-dependent virus-specific CD8+ T cell impairment. Thus, the
suppressive effect of IMs on MCMV-specific CD8+ T cells is
mediated primarily through the iNOS-NO axis.
DISCUSSION
Myelomonocytic cells have long been implicated in CMV patho-
genesis. Here, we have shown the importance of CCR2-medi-
ated emigration of IM out of the BM to sites of viral infection
where they regulate the quality of the T cell response in a mouse130 Immunity 37, 122–133, July 27, 2012 ª2012 Elsevier Inc.strain in which adaptive immunity dominates. The viral chemo-
kine, MCK2, collaborates with CCR2 to affect this regulation.
Despite being aggressively recruited by the combination of
host CCR2 signaling and the elaboration of MCK2, IMs do not
contribute toMCK2-enhanced viral dissemination, which is likely
to be carried out by another susceptible monocytic lineage such
as patrolling monocytes. When recruited to sites of infection, IM
lineage cells modulate adaptive immunity in a manner reminis-
cent of monocytic MDSCs, undermining the effectiveness of
the viral Ag-specific CD8+ T cell response by restricting cytokine
polyfunctionality and cytolytic activity and delaying virus clear-
ance. The overall increase in quality of virus-specific CTLs during
infection of Ccr2/–Ccl2/– mice as well with viral chemokine-
deficient virus serve to reinforce this role.
IM-mediated modulation occurs through the iNOS metabolic
pathway, which is exploited by MCMV to subvert antiviral
CD8+ T cell immunity. For many years, efforts to link viral modu-
lators to compromised virus-specific T cell responses have
focused on MHC class I downregulation (Doom and Hill, 2008).
Instead of altering the characteristics of the T cell response,
MHC class I downmodulation appears to be most relevant in
dictating the susceptibility of virus-infected cells to clearance.
In contrast, the impact of increased IM recruitment is on the
quality of the antiviral CD8+ T cell immunity in lymphoid organs
as well as in other virus-infected tissues that contribute to viral
pathogenesis.
In C57BL/6 mice, CCR2-dependent IMs promote NK cell
activity because of the Ly49H-m157 NK axis, leading to an early
reduction in viral levels (Crane et al., 2009; Hokeness et al.,
2005). While this is a distinct impact compared to BALB/c
mice, greater viral persistence results from IM recruitment in
either strain. Increased IM numbers in BALB/c mice reduce
CTL-mediated clearance. In addition to the early reduction af-
forded by an IM-driven NK response, NK-mediated cytolysis of
APCs in C57BL/6mice reduces CTL levels as assessed by in vivo
killing (Andrews et al., 2010).MCK2 drives the dramaticmobiliza-
tion of IMs to infection sites in either mouse strain. This behavior
has additional implications because the bacterial artificial chro-
mosome-derived MCMV Smith strain, pSM3fr, initially proposed
to exhibit WT properties (Wagner et al., 1999) and used widely to
study host immunity (Ruzsics and Koszinowski, 2008), encodes
a nonfunctional MCK2 protein (Jordan et al., 2011). As a result of
themutation, reduced IM recruitment would be expected to alter
both antiviral NK cell as well as T cell control in ways that will
need careful examination. Besides this issue, future efforts will
need to evaluate more precisely the extent to which IMs directly
regulate CTLs in C57BL/6 mice. The fact that fully competent
MCMV infection promotes pluripotent IMs regardless of mouse
strain indicates that immune regulation through the iNOS-NO
axis probably combines with the indirect impact of NK cell-medi-
ated killing of infected APCs to aid persistent viral replication.
Whether the strategies identified in MCMV are at play during
HCMV infection is unknown, although both a virus-encoded che-
mokine and a role for CTLs in host defense are well documented
(Mocarski et al., 2007). Potentially, CXCR2-specific viral chemo-
kine vCXCL1 encoded by HCMV UL146 (Penfold et al., 1999)
may impact human IMs to regulate CD8+ T cell-specific immu-
nity. Given the existing parallels in MHC class I downmodulation
strategies to escape CTL surveillance common to MCMV
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similarities may occur. On the one hand, viral modulation of
CTL activity has remained elusive despite significant studies
on the regulation of MHC class I expression. On the other
hand, MCK2-recruited IMs facilitate a robust antiviral NK
response that negatively regulates T cell responses to promote
MCMV persistence. The studies reported here reinforce the
importance of CD8+ T cells as a target of viral immune modula-
tion right from the start of infection. As such, the diverse thera-
peutic strategies being applied in clinical settings where HCMV
remains a medical problem will need to consider the impact of
promoting IM responses that could potentially antagonize efforts
to boost adaptive immunity.
IFN-g, in a STAT1-dependent fashion, activates iNOS
(Samardzic et al., 2001), resulting in metabolism of L-arginine
to produce citrulline and NO (Bogdan, 2001). NO-mediated
MDSC suppression of T cell activation and expansion occurs
through the disruption of downstream signaling initiated through
IL-2R binding IL-2 whereby phosphorylation of JAK1, JAK3,
STAT5, ERK, and AKT is precluded (Mazzoni et al., 2002). The
NO-dependent immunosuppressive behavior of the MCK2-tar-
geted, CCR2-dependent IMs in this study is reminiscent of the
phenotypically similar mononuclear MDSCs studied primarily in
tumor immunity. CX3CR1
intCCR2+Ly6Chi cells are a functionally
heterogeneous population containing precursors that follow
discrete differentiation pathways depending on the inflammatory
cue. It is evident by the increasing numbers of reports that micro-
bial infections elicit suppressor CX3CR1
intCCR2+Ly6Chi cells
(De Santo et al., 2008; Delano et al., 2007; Mencacci et al.,
2002). The implication of a NO-mediated pathway as a mecha-
nism of IM immunomodulation elicited during acute MCMV
infection being consistent with monocytic MDSC suggests an
overlap in the inflammatory cues that promote differentiation of
these cells during acute and chronic inflammatory states,
including tumorigenesis. IFN-g is considered crucial for limiting
viral replication (Biron et al., 1999; Koszinowski et al., 1990).
T cells and NK cells probably contribute the IFN-g that activates
iNOS in IMs during MCMV-infection. Accordingly, limiting IFN-g
production would prove to be beneficial to the establishment of
infection. The core activity contributing to the development of IM
suppressive mechanisms can be addressed more comprehen-
sively in settings where IFN-g is regulated. Further parallels to
tumor MDSCs might emerge from investigations in settings
where such key cytokines are absent or restricted.
In conclusion, we have shown that IMs dampen immune
control by CD8+ T cells in a virus infection setting where CTLs
dominate clearance, identifying a specific IM-mediated impair-
ment of CD8+ T cell function that results from the collaboration
of viral and host control. The resulting diminished CTL immunity
facilitates greater viral persistence. This study elucidates how
diverse immunological settings prompt the evolution of distinct
viral modulatory strategies that achieve persistence, highlighting
major aspects of host defense that are critical to the clearance of
infection. Previously, the immunosuppressive effect of IMs on
CD8+ T cells emerged from mouse tumor models engineered
to carry exogenous antigens to facilitate analysis. Our approach
benefited from the existence of a natural Ag-specific T cell
response focused on a particular viral epitope. The environment
that favors MCMV persistence that results from IM-mediatedimpaired T cell function will help inform immune tolerance as
conceptualized in persistent virus infection as well as tumor
progression.
EXPERIMENTAL PROCEDURES
Viruses, Mice, Experimental Infection, and Plaque Assay
MCMV K181+-derived recombinant Mck2 mutant (RM461) and rescued
(RQ461) viruses (Stoddart et al., 1994) were propagated on NIH 3T3 murine
fibroblasts (ATCC CRL-1658) grown in antibiotic-supplemented DMEM
medium (Manning et al., 1992). Virus stocks were prepared from clarified
infected medium (Saederup et al., 1999) and stored at 80C until used to
infect 8- to 16 week-old BALB/cJ (Jackson Laboratories) or Ccr2/–Ccl2/–
BALB/c (Noda et al., 2006)mice used in this study. One hind FPwas inoculated
with 1 3 106 plaque-forming units (PFUs) of virus diluted in medium or virus-
free medium (mock-infected). Mice were maintained at the Emory University
Division of Animal Resources and experimental procedures were conducted
in accordance with National Institutes of Health and Emory University Institu-
tional Animal Care and Use Committee guidelines. Plaque assays were con-
ducted on tissues homogenized in medium (Manning et al., 1992) with 3T3
Swiss Albino murine fibroblasts (ATCC CCL-92). Virus titers were calculated
at 4 days when cells were fixed with methanol and stained with Giemsa for
plaque visualization.
Antibodies
Antibodies to CD16/32 (FcgRII/III; Clone 2.4G2), Ly6C (Clone AL21), Ly6G
(Clone 1A8), CD279 (Clone J43), TNF-a (Clone MP6-XT22), CD4 (Clone
RM4-5), CD11b (Clone M1/70), and CD3ε (Clone 500A2) were purchased
from BD PharMingen; CD45 (Clone 30F11), CD69 (H1.2F3), and F4/80 (Clone
BM8) were purchased from Invitrogen; and IFN-g (Clone XMG1.2), CD62L
(Clone MEL14), CD115 (Clone ASF98), and CD107a (Clone 1D4B) were
purchased from Biolegend. The following Abs were purchased from eBio-
science: CD4 (Clone GK1.5), CD11c (Clone N418), Ly-6A/E (Sca-1; Clone
D7), CD19 (Clone 1D3), CD31 (PECAM-1; Clone 390), CD8a (Clone 53-6.7),
CD49b (Clone DX5), CD8a (53-6.7), Siglec H (Clone eBio440c), CD3ε (Clone
17A2), and Ly6C/6G (Gr-1; Clone RB6.8C5).
Tissue Collection, Leukocyte Preparation, and Flow Cytometry
Tissues were collected from euthanized mice for single-cell suspension
preparation and analysis by flow cytometry. FP and lung tissue were minced
into 3 mm sections then digested with collagenase D (1.5 mg/ml; Sigma)
in PBS. Cells were collected from lung digest, spleen, and pLNs by mashing
through a metal sieve and from femurs by flushing BM and from blood
collected in EDTA-loaded syringes by Histopaque-1119 (Sigma) density
medium separation. Erythrocytes were lysed where applicable, cell prepara-
tions were filtered (40 mm mesh), and viable cells counts were performed on
a hemacytometer with trypan blue dye exclusion. Cell surface FcgRII/III was
blocked prior to incubating with Abs for nine-color flow cytometric analyses.
Data were acquired by flow cytometry (BD LSRII cytometer and FACSDiva
Software; BD Biosciences), analyzed with FlowJo (TreeStar), and graphed
with Prism (GraphPad). For morphological assessments, cells were sorted
(purity >97%; FACSVantage, BD Biosciences), centrifuged onto microscope
slides, and stained with hematoxylin and eosin (Hema3 stain kit; Fisher
Scientific).
For ICCS, cells isolated from tissues were incubated with 109 MMCMV IE1
peptide (YPHFMPTNL, purity >80%; JPT Peptide Technologies) in RPMI
medium containing brefeldin A along with the CD107a Ab for 5 hr at 37C,
then prepared for cytokine detection with the BD GolgiPlug kit (BD
Biosciences).
Latent Infections and Explant Reactivation
Groups of fiveCcr2/–Ccl2/– orWTmicewere inoculated as described above;
the lung, SG, and spleen were collected at 6 months postinfection, divided
into three sections, and cultured as intact sections with DMEM. Supernatant
was collected from culture wells and replaced with fresh DMEM at weekly
intervals for 5 weeks. Viral titers were obtained from the collected supernatant
by plaque assays.Immunity 37, 122–133, July 27, 2012 ª2012 Elsevier Inc. 131
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Target cells were prepared from naive WT or Ccr2/–Ccl2/– mouse spleno-
cytes incubated 1 hr at 37C with 1 mM IE1 peptide, labeled 10 min at 37C
with 5 mM CFSE (CFSEhi, CellTrace; Molecular Probe), then combined (1:1
ratio) with peptide-free splenocytes labeled with 0.5 mM CFSE (CFSElo).
Twenty million target cells (1 3 107 each CFSElo and CFSEhi) were injected
via tail veins into syngeneic recipients at 7 dpi. Recipients were euthanized
at 3 or 15 hr after transfer and CFSE+ cell numbers in spleens were analyzed.
Percent specific killing was calculated as follows: (1– [rnaive/rinfected]) 3 100,
where r = (% CFSElo cells)/(% CFSEhi cells).
Adoptive Transfer
Monocytes were isolated from 3 dpi WT mouse spleens with the EasySep
Mouse Monocyte Enrichment Kit and magnet system (Stemcell Tecnologies).
Purity was assessed at R90% Ly6ChiGr-1loCD11b+ IMs. Purified cells were
adoptively transferred by tail vein injections into groups of n = 3–5 recipient
Ccr2/–Ccl2/– mice that were subsequently inoculated via the FP route with
MCMV. Controls were infected Ccr2/–Ccl2/– mice that received PBS prior
to virus inoculation and infectedWTmice. Spleens were harvested from eutha-
nized mice at 7 dpi, 50% (based on weight) was assessed for virus burden,
and the remaining portion was used in flow cytometry to phenotype virus-
specific CD8+ T cells.
In Vitro CD8+ T Cell Suppression Assay
Mice were infected as described above. Ccr2/–Ccl2/– mouse splenocytes
(responders) were isolated at 7 dpi and labeled with 5 mMCFSE and combined
with IE1 peptide (stimulus; 109 M) in RPMI medium supplemented with 5%
FBS and 50 mM 2-mercaptoethanol before plating in 96-well microtiter plates
(CoStar) at 53 105 cells per well. Purified IMs (suppressors) were immediately
added in 2-fold dilutions except for control wells. Monocytes were purified
from 7 dpi WT mouse spleens with the EasySep kit. At 72 hr, culture superna-
tants were assayed for NO2
 with the Greiss reagent assay (Promega) and
CD8+CD3+ T cell proliferation was evaluated by CFSE dilution. Dead cells
were identified as 7-AAD+. In some instances, NG-Methyl-L-arginine acetate
salt (L-NMMA, 0.5 mM; Sigma-Aldrich), Nu-Hydroxy-nor-L-arginine, diacetate
salt (nor-NOHA, 0.5 mM; Calbiochem), and superoxide dismutase (SOD,
200 U/mL; Sigma-Aldrich) inhibitors were added to the culture wells. Suppres-
sion was calculated as follows: 1003 [1 – (proliferation with IMs)/(proliferation
without IMs)].
In Vivo Inhibition of NOS-Dependent IM Function
WT mice were treated with 4 uM of L-NMMA, NG-Nitro-L-arginine-methyl
ester. HCl (L-NAME; Enzo Life Sciences) or N6-(1-iminoethyl)-L-lysine, dihy-
drochloride (L-NIL; Cayman Chemicals) was administered ad libitum in
drinking water starting 3 days prior to infection. Control group received no
drugs. Drinking water with or without drugs was refreshed every other day
coincident with the weighing of mice. At 7 dpi, tissues were collected and
assessed for viral loads. Half the spleen was used for evaluating CD8+ T cell
responses by flow cytometry.
Statistical Analysis
Experimental groups contained a minimum of three mice. Statistical differ-
ences between groups of mice were calculated with the Student’s t test or
one-way ANOVA with Bonferroni’s or Dunnett’s Multiple Comparison post
tests, with p % 0.05 considered to be significant in the GraphPad Prism 5
software.
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